Whereas in Germany, the market access differs from the systems followed in many other countries as no pricing and reimbursement approval is required during launch of a new therapy
Lamers D, Famulla S, Wronkowitz N, Hartwig S, Lehr S, Ouwens DM, Eckardt K, Kaufman JM, Ryden M, Mller S, Hanisch FG, Ruige J, Arner P, Sell H, Eckel J
GLP-1 receptor agonists are prescription medications that mimic this hormone which is why they lead to reduced appetite and, for many patients, significant weight loss
Notably, the SOS study showed that in people with T2D, achieving and maintaining 15% WL over 15 years was associated with reductions in both micro- and macrovascular complications following BS [54]
They activate the GLP-1 receptor, which stimulates insulin release, slows gastric emptying, and reduces appetite through effects on the brain
CareEdge also expects prices to decline by 4050% in FY27 and by a further 1030% in FY28 as competition intensifies